Published by Josh White on 2nd July 2021
(Sharecast News) - Point-of-need mass spectrometry technology company Microsaic announced on Friday that, in collaboration with the Centre for Process Innovation (CPI), it had developed and demonstrated the first, real-time monitoring process analytical technology (PAT) MS solution for the on-line production of biotherapeutic drugs, such as vaccines and anti-cancer treatments.